Skip to content

A verification study for improving the intestinal environment with consumption of the test food in healthy subjects: an open-label trial

A verification study for improving the intestinal environment with consumption of the test food in healthy subjects: an open-label trial - A verification study for improving the intestinal environment with consumption of the test food in healthy subjects

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000035244
Enrollment
10
Registered
2018-12-13
Start date
2018-12-14
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy Japanese subjects

Interventions

Duration: 2 weeks Test food: Manda Koso Administration: Take 5 packs per day after breakfast. Take the packs with water as necessary. * If you forget to take the test food, take it as soon as you

Sponsors

ORTHOMEDICO Inc.
Lead Sponsor
Medical Corporation Seishinkai, Takara Clinic
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Healthy Japanese adult subjects who defecate three to five times per week 2. Subjects who are judged as eligible to participate in the study by the physician 3. Subjects who have relatively few defecation frequency at a week before screening (before consumption)

Exclusion criteria

Exclusion criteria: 1. Subjects who are undergoing medical treatment or have a medical history of malignant tumor, heart failure or myocardial infarction 2. Subjects who have a pacemaker or an implantable cardioverter defibrillator (ICD) 3. Currently undergoing treatment for any of the following chronic diseases: cardiac arrhythmia, liver disease, kidney disease, cerebrovascular disorder, rheumatism, diabetes mellitus, dyslipidemia, hypertension, or any other chronic diseases 4. Subjects who use or take "Foods for Specified Health Uses", "Foods with Function Claims", or other functional food/beverage in daily 5. Subjects who are currently taking medications (including herbal medicines) and dietary supplements 6. Subjects who are allergic to medicines and/or the test food related products especially orange, walnut, sesame seeds, soybean, banana, and apple 7. Subjects who are pregnant, breast-feeding, or planning to become pregnant 8. Subjects who have been enrolled in other clinical trials within the last three months before the agreement to participate in this trial or plan to participate another trial during this trial 9. Subjects who are ineligibility to participate in the study based on the evaluation of the physician

Design outcomes

Primary

MeasureTime frame
1. Defecation days 2. Defecation frequency 3. Amount of defecation 4. Shape of stool 5. Smell of stool 6. Exhilarating feeling *1-6 Record the diary from a week before screening (before consumption) to the day before screening (before consumption) and from a week before consuming to the day before 4 weeks after consuming

Secondary

MeasureTime frame
1. Firmicutes 2. Bacteroidetes 3. Actinobacteria 4. Proteobacteria 5. Lactobacillaceae 6. Bacteroidaceae 7. Lactobacillus 8. Clostridium 9. Roseburia 10. Ruminococcus 11. Eubacterium 12. Bifidobacterium 13. Bacteroides 14. Anaerostipes 15. The Japanese version of Constipation Assessment Scale MT version (CAS-MT) 16. Bristol stool scale 17. Succinic acid 18. Lactic acid 19. Formic acid 20. Acetic acid 21. Propionic acid 22. Isobutyric acid 23. n-Butyric acid 24. Isovaleric acid 25. n-Valeric acid 26. Indole 27. Skatole *1-14 Analyze the intestinal environment by metagenomics *1-14 Calculate the abundance ratio of each bacterium *1-15, 17-27 Assess the measured value at screening (before consumption) and at 2 weeks after consumption and calculate the amount of change. *16 Assess the measured value at screening (before consumption) and at 2 weeks after consumption.

Countries

Japan

Contacts

Public ContactNaoko SUZUKI

ORTHOMEDICO Inc. R&D Department

nao@orthomedico.jp03-3818-0610

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026